The event of mutations in the surface antigen gene of hepatitis B virus (HBV) results in
undetectable hepatitis B surface antigen with positive/negative anti-hepatitis B core (anti …

Multiple new therapeutic approaches are currently being developed to achieve sustained,
off-treatment suppression of HBV, a persistent hepatotropic infection that kills~ 2,000 people …

B cells are increasingly recognized as playing an important role in the ongoing control of
hepatitis B virus (HBV). The development of antibodies against the viral surface antigen …

Chronic HBV (CHB) infection suppresses virus-specific T cells, but its impact on humoral
immunity has been poorly analyzed. Here, we developed a dual-staining method that …

Chronic hepatitis B virus (HBV) infection is a complex clinical entity frequently associated
with cirrhosis and hepatocellular carcinoma (HCC). The persistence of HBV genomes in the …

Historically, viruses were considered to be either enveloped or nonenveloped. However,
recent work on hepatitis A virus and hepatitis E virus challenges this long-held tenet …

The majority of infectious hepatitis C particles are present in the low-density fractions from
plasma of infected patients, suggesting an association of the virus with lipoproteins and the …

Summary The neonatal Fc receptor, FcRn, is best known for its role in transporting IgG in
various tissues, providing newborns with humoral immunity, and for prolonging the half‐life …

Five hepatitis viruses (hepatitis A to E) are the leading causes of liver disease worldwide.
Among them, hepatitis B virus (HBV) is responsible for approximately 350 million chronic …

Since the early 1990's, hepatitis B immune globulin (HBIG) has been central to the
prevention of hepatitis B virus (HBV) recurrence after liver transplantation. When used in …